Experimental Hematology
Volume 38, Issue 6 , Pages 481-488 , June 2010

Activation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins

  • Ming-Him James Ng

      Affiliations

    • Division of Haematology, The SH Ho Foundation Research Laboratories in Pathology, Department of Pathology, The University of Hong Kong, Pokfulam, Hong Kong SAR, PR China
    • Department of Biochemistry, The University of Hong Kong, Pokfulam, Hong Kong SAR, PR China
    • ,
  • Ray Kit Ng

      Affiliations

    • Division of Haematology, The SH Ho Foundation Research Laboratories in Pathology, Department of Pathology, The University of Hong Kong, Pokfulam, Hong Kong SAR, PR China
    • ,
  • Cheuk-Ting Kong

      Affiliations

    • Division of Haematology, The SH Ho Foundation Research Laboratories in Pathology, Department of Pathology, The University of Hong Kong, Pokfulam, Hong Kong SAR, PR China
    • Department of Biochemistry, The University of Hong Kong, Pokfulam, Hong Kong SAR, PR China
    • ,
  • Dong-Yan Jin

      Affiliations

    • Department of Biochemistry, The University of Hong Kong, Pokfulam, Hong Kong SAR, PR China
    • ,
  • Li-Chong Chan

      Affiliations

    • Division of Haematology, The SH Ho Foundation Research Laboratories in Pathology, Department of Pathology, The University of Hong Kong, Pokfulam, Hong Kong SAR, PR China
    • Corresponding Author InformationOffprint requests to: Li-Chong Chan, Ph.D., Division of Hematology, Department of Pathology, The University of Hong Kong, University Pathology Building, Queen Mary Hospital, 102 Pokfulam Road, Pokfulam, Hong Kong, SAR, PR China

Received 2 October 2008 ,Revised 8 March 2010 ,Accepted 23 March 2010.

References 

  1. Daser A, Rabbitts TH. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Semin Cancer Biol. 2005;15:175–188
  2. Meyer C, Schneider B, Jakob S, et al. The MLL recombinome of acute leukemias. Leukemia. 2006;20:777–784
  3. So CW, Cleary ML. Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood. 2003;101:633–639
  4. Zeisig BB, Schreiner S, Garcia-Cuellar MP, Slany RK. Transcriptional activation is a key function encoded by MLL fusion partners. Leukemia. 2003;17:359–365
  5. So CW, Lin M, Ayton PM, Chen EH, Cleary ML. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell. 2003;4:99–110
  6. Martin ME, Milne TA, Bloyer S, et al. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell. 2003;4:197–207
  7. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev. 2003;3:11–22
  8. Wittwer F, van der Straten A, Keleman K, Dickson BJ, Hafen E. Lilliputian: an AF4/FMR2-related protein that controls cell identity and cell growth. Development. 2001;128:791–800
  9. Mahgoub N, Parker RI, Hosler MR, et al. RAS mutations in pediatric leukemias with MLL gene rearrangements. Genes Chromosomes Cancer. 1998;21:270–275
  10. Shih LY, Liang DC, Fu JF, et al. Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia. 2006;20:218–223
  11. So CW, Caldas C, Liu MM, et al. EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. Proc Natl Acad Sci U S A. 1997;94:2563–2568
  12. Yam JW, Jin DY, So CW, Chan LC. Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein. Blood. 2004;103:1445–1453
  13. Ching YP, Chan SF, Jeang KT, Jin DY. The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat Cell Biol. 2006;8:717–724
  14. Kong CT, Sham MH, So CW, Cheah KS, Chen SJ, Chan LC. The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice. Leukemia. 2006;20:1829–1839
  15. Thomas M, Gessner A, Vornlocher HP, Hadwiger P, Greil J, Heidenreich O. Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells. Blood. 2005;106:3559–3566
  16. Dick JE. Stem cells: self-renewal writ in blood. Nature. 2003;423:231–233
  17. Dick JE. Acute myeloid leukemia stem cells. Ann N Y Acad Sci. 2005;1044:1–5
  18. Wang JC, Dick JE. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 2005;15:494–501
  19. Nakanishi H, Nakamura T, Canaani E, Croce CM. ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias. Proc Natl Acad Sci U S A. 2007;104:14442–14447
  20. Luscher-Firzlaff J, Gawlista I, Vervoorts J, et al. The human trithorax protein hASH2 functions as an oncoprotein. Cancer Res. 2008;68:749–758
  21. Ono R, Kumagai H, Nakajima H, et al. Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation. Leukemia. 2009;23:2197–1209
  22. Kim WI, Matise I, Diers MD, Largaespada DA. RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia. Blood. 2009;113:1086–1096

PII: S0301-472X(10)00105-0

doi: 10.1016/j.exphem.2010.03.014

Experimental Hematology
Volume 38, Issue 6 , Pages 481-488 , June 2010

Article Tools

* Image Usage & Resolution